Biodistribution of 213Bi–Metallothionein and 213Bi–IgG in Intact Mice radionuclide. The results of studying the biodistribution of 213Bi–metallothionein (213Bi–MT), 213Bi–
immunoglobulin INFLIXIMAB IN THE TREATMENT OF IMMUNOGLOBULIN-RESISTANT KAWASAKI DISEASE, skin, and lymph nodes. The initial KD therapy is intravenous
immunoglobulin (IVIG) at a dose of 2 g